To accomplish this initiative, the labs (detl, PHL, SJN) must update and upgrade technologies so the workload can be more readily shared amongst the labs. Additionally, prior to FDA realignment update…
Ended Purchase Order Awarded Last action
- Contract number
- 75F40122P00395
- Awardee
-
Waters Corporation UEI ERVJKCK3HZA6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- Dissolution System with UV-Vis Detector and Sampling System Solicitation · 1255140 · Posted Jun 7, 2022
- Contract value 0% obligated
- $68,012.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Detroit, MI 48207, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $68,012 |
About this award
The Food and Drug Administration awarded a $68,012 firm fixed-price purchase order to Waters Corporation on September 26, 2022, for equipment and technology upgrades to support laboratory operations at three FDA facilities: the Detroit Experimental Testing Laboratory, the Philadelphia Laboratory, and the San Juan Laboratory. The contract aims to modernize analytical instrumentation across these sites to facilitate more efficient workload sharing and distribution among the laboratories. This initiative addresses technology gaps that had previously limited equipment upgrade prioritization prior to FDA organizational realignment efforts. The contract is scheduled for completion by March 4, 2026, with performance taking place in Detroit, Michigan. No small business set-aside was utilized for this award.
Waters Corporation, a global leader in analytical instrumentation headquartered in Milford, Massachusetts, regularly provides specialized scientific equipment and solutions to federal agencies, including the FDA. The company's federal contract portfolio demonstrates extensive experience delivering high-precision instruments such as liquid chromatography systems, mass spectrometers, and related laboratory equipment through firm fixed-price purchase orders and General Services Administration schedule contracts. This award reflects Waters Corporation's established position as a primary supplier of advanced analytical instrumentation to support the FDA's laboratory capabilities and operational efficiency initiatives.
Description
To accomplish this initiative, the labs (detl, PHL, SJN) must update and upgrade technologies so the workload can be more readily shared amongst the labs. Additionally, prior to FDA realignment update and upgrading of equipment had been low priorit
Quick answers
Who was awarded contract 75F40122P00395?
75F40122P00395 was awarded to Waters Corporation by Food and Drug Administration (Department of Health and Human Services) on September 26, 2022.
How much is contract 75F40122P00395 worth?
The government has obligated $0 on 75F40122P00395. Its current value, with exercised options, is $68,012.
Was contract 75F40122P00395 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award